You have 9 free searches left this month | for more free features.

Locally Advanced

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Combined Postoperative Radiotherapy With Kidney Sparing Surgery

Recruiting
  • Locally Advanced
  • Urothelial Carcinoma Ureter
  • Radical surgery
  • Kidney sparing surgery+Postoperative radiotheray
  • Beijing, China
  • +1 more
Nov 2, 2023

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Recurrent Vulvar Cancer
  • +3 more
  • (no location specified)
Jun 12, 2023

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Colon Cancer, Immunotherapy Trial in Chongqing (Terelizumab, CapeOx)

Not yet recruiting
  • Colon Cancer
  • Immunotherapy
  • Chongqing, China
    Daping hospital
Apr 16, 2023

Pulmonary Tumor, Advanced Cancer, Locally Advanced Cancer Trial in Shanghai (Surgery)

Recruiting
  • Pulmonary Neoplasm
  • +2 more
  • Surgery
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai JiaoTong University School of Medicine
Dec 15, 2022

Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H

Recruiting
  • Colorectal Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 18, 2023

    Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in

    Not yet recruiting
    • Locally Advanced Cholangiocarcinoma
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
        CHA Bundang Medical Center
      Jan 24, 2023

      Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

      Recruiting
      • Thymic Carcinoma
      • Envolizumab combined with radiotherapy
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Sep 3, 2023

      Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

      Recruiting
      • Differentiated Thyroid Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 9, 2023

      Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)

      Recruiting
      • Locally Advanced Nasopharyngeal Carcinoma
      • 2 cycles induction chemotherapy
      • 3 cycles induction chemotherapy
      • Guangzhou, Other (Non U.s.), China
        First Affiliated Hospital, Sun Yat-Sen University
      May 6, 2023

      Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)

      Not yet recruiting
      • Rectal Cancer
      • CapeOX + cetuximab
      • +2 more
      • (no location specified)
      Sep 12, 2023

      Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

      Recruiting
      • Cervical Cancer
      • +2 more
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Institute & Hospital
      Oct 16, 2023

      Contribution of PET/MRI in Locally Advanced Cervical Cancer

      Not yet recruiting
      • Cervical Cancer
      • 18-FDG PET-MRI
      • Strasbourg, France
        Institut de cancérologie Strasbourg Europe
      Oct 12, 2023

      Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Tiragolumab)

      Not yet recruiting
      • Locally Advanced Esophageal Squamous Cell Carcinoma
      • (no location specified)
      Feb 23, 2023

      Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)

      Not yet recruiting
      • Locally Advanced Solid Tumors
      • +2 more
      • (no location specified)
      Sep 4, 2023

      Solid Tumors Trial (IBR854 Cell Injection)

      Not yet recruiting
      • Solid Tumors
      • IBR854 Cell Injection
      • (no location specified)
      Aug 14, 2023

      Plasma MRD and cfDNA HPV and Efficacy and Prognosis of Locally

      Recruiting
      • Locally Advanced Cervical Cancer
      • Concurrent chemoradiotherapy
      • Guiyang, Guizhou, China
        Yong Li
      Jul 14, 2023

      GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

      Not yet recruiting
      • Salivary Gland Cancer
      • Observation
      • (no location specified)
      Oct 13, 2023

      Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

      Not yet recruiting
      • Locally Advanced
      • +3 more
      • Guangzhou, Guangdong, China
        Nanfang Hospital Southern Medical University
      May 17, 2023

      Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)

      Not yet recruiting
      • Locally Advanced Rectal Cancer
      • Beijing, China
      • +1 more
      Sep 21, 2023

      Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial (ES014)

      Not yet recruiting
      • Solid Tumor
      • +2 more
      • (no location specified)
      Jan 28, 2023

      Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

      Recruiting
      • Metastatic Breast Cancer
      • +2 more
      • Ocala, Florida
        Ocala Oncology Center PL DBA Florida Cancer Affiliates
      Jul 19, 2023

      Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced

      Completed
      • Oral Cancer
      • PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital
      Nov 20, 2023

      Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body

      Not yet recruiting
      • Pancreas Cancer
      • +2 more
      • Stereotactic Ablative Body Radiation (SABR)
      • Tumor Treating Fields (TTF)
      • Miami, Florida
        Miami Cancer Institute at Baptist Health, Inc.
      Dec 27, 2022